Insider Trading March 24, 2026

Exzeo Director Adds 4,000 Shares as Company Posts Q4 and Full-Year 2025 Results In Line With Forecasts

James J. Macchiarola increases direct stake; Exzeo reports EPS of $0.25 and Q4 revenue of $53.32 million

By Nina Shah XZO
Exzeo Director Adds 4,000 Shares as Company Posts Q4 and Full-Year 2025 Results In Line With Forecasts
XZO

Exzeo Group Director James J. Macchiarola bought 4,000 shares on March 23, 2026 at $15.12 per share, a $60,480 transaction that brings his direct holdings to 140,000 shares. Separately, Exzeo reported fourth-quarter and full-year 2025 results that matched earnings expectations, recording diluted EPS of $0.25 and quarterly revenue of $53.32 million. Analysts have noted the results and may consider rating changes as investors assess the company’s stability and growth prospects.

Key Points

  • Director James J. Macchiarola purchased 4,000 shares at $15.12 on March 23, 2026, totaling $60,480 and raising his direct holdings to 140,000 shares.
  • Exzeo reported fourth-quarter and full-year 2025 results that matched forecasts, with diluted EPS of $0.25 and quarterly revenue of $53.32 million.
  • Analysts have noted the results and may revise stock ratings, which could influence investor sentiment in the equity markets and related sectors.

Exzeo Group, Inc. reported an insider purchase on March 23, 2026, when director James J. Macchiarola acquired 4,000 shares of the company’s common stock at $15.12 per share. The transaction totaled $60,480. Following the purchase, Macchiarola’s direct ownership in Exzeo stands at 140,000 shares.

In its corporate results, Exzeo disclosed fourth-quarter and full-year 2025 financial outcomes that came in line with earnings forecasts. The company recorded diluted earnings per share (EPS) of $0.25 for the quarter and reported quarterly revenue of $53.32 million. The results were presented as consistent with market expectations and were described as reflecting meaningful growth.

Market observers and financial analysts have taken note of Exzeo’s reported figures. The company’s ability to meet consensus forecasts is highlighted as important for sustaining investor confidence. Some analyst firms are reportedly evaluating the results and may adjust their stock ratings based on the quarter and full-year disclosures. The company’s financial stability and prospects for continued growth remain under review by investors and analysts alike.

These developments - the insider purchase and the earnings report - were disclosed without additional forward-looking detail. Exzeo’s reported matching of forecasts is presented as an indication of a steady outlook; nonetheless, market participants will continue to monitor any subsequent disclosures or developments that could affect investor sentiment and analyst recommendations.


Summary

Director James J. Macchiarola purchased 4,000 Exzeo shares on March 23, 2026 for $60,480, increasing his direct holdings to 140,000 shares. Separately, Exzeo’s fourth-quarter and full-year 2025 results matched expectations with diluted EPS of $0.25 and quarterly revenue of $53.32 million. Analysts are reviewing the results and may alter ratings as they assess the firm’s performance and outlook.

Key points

  • Insider activity: Director purchase of 4,000 shares at $15.12 per share, totaling $60,480; direct holdings now 140,000 shares - relevant to corporate governance and investor signaling.
  • Earnings alignment: Fourth-quarter and full-year 2025 results met consensus forecasts with diluted EPS of $0.25 and quarterly revenue of $53.32 million - important for equity investors and market confidence.
  • Analyst attention: Firms are reviewing the results and may adjust ratings, which could influence investor decisions in the equity markets and sectors tracking corporate earnings.

Risks and uncertainties

  • Analyst reaction risk - Potential rating changes by analysts could affect market sentiment toward Exzeo and influence trading in the company’s stock.
  • Information limitations - The disclosed items do not include forward-looking guidance or additional detail; the absence of such information leaves investors reliant on the reported figures and any future disclosures.
  • Market monitoring risk - Continued market scrutiny means subsequent developments could alter perceptions of Exzeo’s stability and growth prospects, impacting investor confidence in the equity market.

Risks

  • Analyst rating changes could affect investor sentiment and share performance in the equity market.
  • The company’s disclosures lack additional forward-looking detail, limiting visibility for investors and increasing reliance on reported results.
  • Further developments or disclosures could shift market perceptions of Exzeo’s financial stability and growth prospects.

More from Insider Trading

Exzeo CEO Purchases $29,980 of Stock as Shares Trade Below Purchase Price Mar 24, 2026 Guardian Pharmacy CFO Disposes $5.6 Million in Stock Amid Recent Offering Mar 24, 2026 Hims & Hers CFO Sells $219K in Stock Amid Rapid Share Rally and Novo Nordisk Partnership Mar 24, 2026 Marcus Corp Insider Sale: President Disposes of Small Stake as Company Posts Mixed Quarterly Results Mar 24, 2026 Viatris Accounting Chief Disposes $283,538 in Stock; Company Outlines Multi-Year Growth Targets Mar 24, 2026